
A 2026 evidence matrix for FDA digitally derived measures, covering endpoint roles, verification, validation, missingness, change control, and a stride-length example.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

A 2026 evidence matrix for FDA digitally derived measures, covering endpoint roles, verification, validation, missingness, change control, and a stride-length example.

A 2026 analyst guide to FDA's GenAI medical device discussion paper, with a two-axis risk matrix, competency evidence plan, lifecycle monitoring controls, and 30/60/90-day readiness actions.

A 2026 MedTech AI quality benchmark for clinical validation, PCCP maturity, model traceability, postmarket monitoring, survey methods, and a reproducible FDA appendix.

Explore clinical evidence requirements for AI diagnostic tools. Covers FDA/EU regulations, prospective vs. retrospective validation, and performance standards.
© 2026 IntuitionLabs. All rights reserved.